These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 8245483

  • 1. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus.
    Nagafuchi H, Suzuki N, Mizushima Y, Sakane T.
    J Immunol; 1993 Dec 01; 151(11):6525-34. PubMed ID: 8245483
    [Abstract] [Full Text] [Related]

  • 2. Inhibitory effect of anti-class II antibody on the spontaneous activation of B cells in patients with systemic lupus erythematosus. Analysis with IL-1 production and IL-1 receptor expression.
    Tanaka Y, Saito K, Suzuki H, Eto S, Yamashita U.
    J Immunol; 1989 Sep 01; 143(5):1584-90. PubMed ID: 2527267
    [Abstract] [Full Text] [Related]

  • 3. B cell hyperactivity is a function of T cell derived cytokines in systemic lupus erythematosus.
    al-Janadi M, Raziuddin S.
    J Rheumatol; 1993 Nov 01; 20(11):1885-91. PubMed ID: 7508509
    [Abstract] [Full Text] [Related]

  • 4. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
    Morimoto S, Nakano S, Watanabe T, Tamayama Y, Mitsuo A, Nakiri Y, Suzuki J, Nozawa K, Amano H, Tokano Y, Kobata T, Takasaki Y.
    Rheumatology (Oxford); 2007 Jul 01; 46(7):1083-6. PubMed ID: 17500077
    [Abstract] [Full Text] [Related]

  • 5. Expression and function of inducible costimulator on peripheral blood T cells in patients with systemic lupus erythematosus.
    Yang JH, Zhang J, Cai Q, Zhao DB, Wang J, Guo PE, Liu L, Han XH, Shen Q.
    Rheumatology (Oxford); 2005 Oct 01; 44(10):1245-54. PubMed ID: 15987711
    [Abstract] [Full Text] [Related]

  • 6. Estrogen enhancement of anti-double-stranded DNA antibody and immunoglobulin G production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Kanda N, Tsuchida T, Tamaki K.
    Arthritis Rheum; 1999 Feb 01; 42(2):328-37. PubMed ID: 10025928
    [Abstract] [Full Text] [Related]

  • 7. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
    Kawamoto M, Harigai M, Hara M, Kawaguchi Y, Tezuka K, Tanaka M, Sugiura T, Katsumata Y, Fukasawa C, Ichida H, Higami S, Kamatani N.
    Arthritis Res Ther; 2006 Feb 01; 8(3):R62. PubMed ID: 16563187
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-6 is responsible for aberrant B-cell receptor-mediated regulation of RAG expression in systemic lupus erythematosus.
    Hillion S, Garaud S, Devauchelle V, Bordron A, Berthou C, Youinou P, Jamin C.
    Immunology; 2007 Nov 01; 122(3):371-80. PubMed ID: 17608810
    [Abstract] [Full Text] [Related]

  • 9. RP105-lacking B cells from lupus patients are responsible for the production of immunoglobulins and autoantibodies.
    Kikuchi Y, Koarada S, Tada Y, Ushiyama O, Morito F, Suzuki N, Ohta A, Miyake K, Kimoto M, Horiuchi T, Nagasawa K.
    Arthritis Rheum; 2002 Dec 01; 46(12):3259-65. PubMed ID: 12483730
    [Abstract] [Full Text] [Related]

  • 10. [Spontaneous production of interleukin-1 and B cell stimulating factors by B cells from patients with systemic lupus erythematosus].
    Hirose T.
    Ryumachi; 1989 Aug 01; 29(4):277-83. PubMed ID: 2617369
    [Abstract] [Full Text] [Related]

  • 11. Decreased expression of interleukin-21 receptor on peripheral B lymphocytes in systemic lupus erythematosus.
    Mitoma H, Horiuchi T, Kimoto Y, Tsukamoto H, Uchino A, Tamimoto Y, Miyagi Y, Harada M.
    Int J Mol Med; 2005 Oct 01; 16(4):609-15. PubMed ID: 16142394
    [Abstract] [Full Text] [Related]

  • 12. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.
    Garaud S, Le Dantec C, Jousse-Joulin S, Hanrotel-Saliou C, Saraux A, Mageed RA, Youinou P, Renaudineau Y.
    J Immunol; 2009 May 01; 182(9):5623-32. PubMed ID: 19380809
    [Abstract] [Full Text] [Related]

  • 13. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus.
    Llorente L, Richaud-Patin Y, Wijdenes J, Alcocer-Varela J, Maillot MC, Durand-Gasselin I, Fourrier BM, Galanaud P, Emilie D.
    Eur Cytokine Netw; 1993 May 01; 4(6):421-7. PubMed ID: 8186374
    [Abstract] [Full Text] [Related]

  • 14. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
    Tao J, Dong J, Li Y, Liu YQ, Yang J, Wu Y, Li L, Shen GX, Tan ZJ, Tu YT.
    J Eur Acad Dermatol Venereol; 2009 Apr 01; 23(4):433-7. PubMed ID: 19335730
    [Abstract] [Full Text] [Related]

  • 15. Correlation of T and B cell activities in vitro and serum IL-2 levels in systemic lupus erythematosus.
    Huang YP, Perrin LH, Miescher PA, Zubler RH.
    J Immunol; 1988 Aug 01; 141(3):827-33. PubMed ID: 3135313
    [Abstract] [Full Text] [Related]

  • 16. Hyperreactivity of activated B cells to B cell growth factor in patients with systemic lupus erythematosus.
    Ueda Y, Sakane T, Tsunematsu T.
    J Immunol; 1989 Dec 15; 143(12):3988-93. PubMed ID: 2592765
    [Abstract] [Full Text] [Related]

  • 17. Characterization of T lymphocyte subpopulations responsible for deficient interleukin 2 activity in patients with systemic lupus erythematosus.
    Murakawa Y, Takada S, Ueda Y, Suzuki N, Hoshino T, Sakane T.
    J Immunol; 1985 Jan 15; 134(1):187-95. PubMed ID: 3917275
    [Abstract] [Full Text] [Related]

  • 18. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.
    Ohtsuka K, Gray JD, Stimmler MM, Toro B, Horwitz DA.
    J Immunol; 1998 Mar 01; 160(5):2539-45. PubMed ID: 9498800
    [Abstract] [Full Text] [Related]

  • 19. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus.
    Nambiar MP, Fisher CU, Warke VG, Krishnan S, Mitchell JP, Delaney N, Tsokos GC.
    Arthritis Rheum; 2003 Jul 01; 48(7):1948-55. PubMed ID: 12847689
    [Abstract] [Full Text] [Related]

  • 20. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients.
    Hahn BH, Anderson M, Le E, La Cava A.
    Arthritis Rheum; 2008 Aug 01; 58(8):2488-97. PubMed ID: 18668553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.